BioCentury
ARTICLE | Clinical News

BioPlex 2200 Anti-CCP test regulatory update

October 18, 2010 7:00 AM UTC

FDA granted 510(k) clearance to Bio-Rad's BioPlex 2200 Anti-CCP test for the early detection of rheumatoid arthritis. Bio-Rad said it also launched the test in the U.S. and already markets it outside ...